153 related articles for article (PubMed ID: 30205184)
1. Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program.
Kulzer B; Daenschel W; Daenschel I; Schramm W; Messinger D; Weissmann J; Vesper I; Parkin CG; Heinemann L
Diabetes Res Clin Pract; 2018 Oct; 144():200-212. PubMed ID: 30205184
[TBL] [Abstract][Full Text] [Related]
2. Benefit of Digital Tools Used for Integrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program.
Heinemann L; Schramm W; Koenig H; Moritz A; Vesper I; Weissmann J; Kulzer B
J Diabetes Sci Technol; 2020 Mar; 14(2):240-249. PubMed ID: 31378074
[TBL] [Abstract][Full Text] [Related]
3. Integrated Personalized Diabetes Management (PDM): Design of the ProValue Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabetes.
Kulzer B; Daenschel W; Daenschel I; Siegel EG; Schramm W; Parkin CG; Messinger D; Weissmann J; Djuric Z; Mueller A; Vesper I; Heinemann L
J Diabetes Sci Technol; 2016 May; 10(3):772-81. PubMed ID: 26645793
[TBL] [Abstract][Full Text] [Related]
4. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
[TBL] [Abstract][Full Text] [Related]
5. Effects of physician's diabetes self-management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self-monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open-labeled, prospective randomized clinical trial.
Tanaka N; Yabe D; Murotani K; Yamaguchi Y; Fujita Y; Kubota S; Nakashima-Yasuda R; Kubota-Okamoto S; Ueno S; Yamazaki Y; Kuwata H; Watanabe K; Hyo T; Hamamoto Y; Kurose T; Higashiyama H; Seino Y; Yamada Y; Seino Y
J Diabetes Investig; 2021 Dec; 12(12):2221-2231. PubMed ID: 34087060
[TBL] [Abstract][Full Text] [Related]
6. The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986].
Polonsky W; Fisher L; Schikman C; Hinnen D; Parkin C; Jelsovsky Z; Amstutz L; Schweitzer M; Wagner R
BMC Fam Pract; 2010 May; 11():37. PubMed ID: 20482765
[TBL] [Abstract][Full Text] [Related]
7. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Kennedy L; Herman WH; Strange P; Harris A;
Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
[TBL] [Abstract][Full Text] [Related]
8. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study.
Polonsky WH; Fisher L; Schikman CH; Hinnen DA; Parkin CG; Jelsovsky Z; Axel-Schweitzer M; Petersen B; Wagner RS
Diabetes Technol Ther; 2011 Aug; 13(8):797-802. PubMed ID: 21568751
[TBL] [Abstract][Full Text] [Related]
9. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
[TBL] [Abstract][Full Text] [Related]
10. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.
Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR
BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495
[TBL] [Abstract][Full Text] [Related]
11. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study.
Polonsky WH; Fisher L; Schikman CH; Hinnen DA; Parkin CG; Jelsovsky Z; Petersen B; Schweitzer M; Wagner RS
Diabetes Care; 2011 Feb; 34(2):262-7. PubMed ID: 21270183
[TBL] [Abstract][Full Text] [Related]
12. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
[TBL] [Abstract][Full Text] [Related]
13. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
Puhr S; Calhoun P; Welsh JB; Walker TC
Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
[TBL] [Abstract][Full Text] [Related]
15. Self-monitoring of blood glucose with finger tip versus alternative site sampling: effect on glycemic control in insulin-using patients with type 2 diabetes.
Knapp PE; Showers KM; Phipps JC; Speckman JL; Sternthal E; Freund KM; Ash AS; Apovian CM
Diabetes Technol Ther; 2009 Apr; 11(4):219-25. PubMed ID: 19344196
[TBL] [Abstract][Full Text] [Related]
16. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
17. Use of a Combined Blood-Glucose- and ß-Ketone-Measuring Device Improves Glycemic Control in Insulin-Treated Patients With Diabetes: The Gold Plus Study.
Ziegler R; Eichholz R; Schulz B
J Diabetes Sci Technol; 2015 May; 9(6):1270-4. PubMed ID: 25986628
[TBL] [Abstract][Full Text] [Related]
18. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
Billings LK; Parkin CG; Price D
Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
[TBL] [Abstract][Full Text] [Related]
19. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control.
Meier JL; Swislocki AL; Lopez JR; Noth RH; Bartlebaugh P; Siegel D
Am J Manag Care; 2002 Jun; 8(6):557-65. PubMed ID: 12068962
[TBL] [Abstract][Full Text] [Related]
20. Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study.
Mora P; Buskirk A; Lyden M; Parkin CG; Borsa L; Petersen B
Diabetes Technol Ther; 2017 Dec; 19(12):715-722. PubMed ID: 29027812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
